ArticleBreast cancer research : BCR2025

Multimodal recurrence risk prediction model for HR+/HER2- early breast cancer following adjuvant chemo-endocrine therapy: integrating pathology image and clinicalpathological features.

Xiaoyan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.